TYRODERM CREAM

If symptoms persist or worsen after 3 to 4 days, or if additional symptoms such as high fever, headache, nausea, or vomiting develop, medical advice should be sought. Excessive dosing, overly short dosing intervals, or use of the product on damaged mucosa may result in increased plasma concentrations and serious adverse reactions (see section 4.9). The product should not be used in the oral cavity or throat in the presence of large acute wounds. The product should be administered with caution in acutely ill or frail elderly patients, who are more susceptible to its adverse effects. Aspegola may cause numbness of the tongue and may increase the risk of bite injury. Throat anaesthesia induced by this medicinal product may lead to pulmonary aspiration (coughing during eating that gives the impression of choking). Patients should be aware that the induction of topical anaesthesia can impair swallowing and thereby increase the risk of aspiration. It is therefore essential that this product is not used before eating or drinking. This medicinal product contains isomalt and maltitol. Patients with rare hereditary problems of fructose intolerance should not use this product. This medicinal product contains less than 1 mmol sodium (23 mg) per dose, that is to say essentially "sodium-free". The colourant sunset yellow FCF (E110) may cause allergic reactions.